Table 2.
Clinical and laboratory characteristics of patients with various MPVLR values on admission.
| Low group (MPVLR ≤ 15.1, n = 50) | High group (MPVLR > 15.1, n = 51) | P | |
|---|---|---|---|
| Gender (male/female) | 9/41 | 9/42 | 0.831 |
| Age (years) | 51.4 ± 13.0 | 54.4 ± 10.3 | 0.193 |
| Total protein (g/L) | 60.0 (55.3-66.6) | 59.7 (55.8-64.5) | 0.847 |
| Albumin (g/L) | 30.0 (25.8-33.2) | 28.9 (26.4-32.1) | 0.407 |
| AST (U/L) | 52.5 (35.0-74.0) | 47.0 (29.0-70.8) | 0.262 |
| Serum creatinine (μmol/L) | 74.0 (62.0-84.0) | 74.0 (60.3-98.5) | 0.755 |
| Total bilirubin (μmol/L) | 41.5 (21.0-103.0) | 68.0 (27.8-154.3) | 0.097 |
| INR | 1.44 ± 0.36 | 1.60 ± 0.41 | 0.032 |
| MPV (fl) | 15.1 (13.8-17.5) | 16.8 (13.6-19.5) | 0.039 |
| Lymphocyte count (×109/L) | 1.40 (1.20-2.10) | 0.70 (0.50-0.80) | <0.001 |
| MPVLR | 9.9 (8.4-12.0) | 25.3 (18.8-37.6) | <0.001 |
| PLTs (×109/L) | 91.0 (65.0-159.0) | 44.0 (28.8-80.0) | <0.001 |
| MELD score | 10.9 (6.3-17.8) | 15.2 (11.8-17.8) | 0.011 |
| CP score | 9.0 (8.0-11.0) | 9.0 (8.3-11.0) | 0.140 |
Data are expressed as n, mean ± SD, or median (interquartile range). Abbreviations: ALT: alanine aminotransferase; AST: aspartate aminotransferase; INR: international normalized ratio; MPV: mean platelet volume; MPVLR: mean platelet volume/lymphocyte ratio; PLTs: platelet counts; MELD score: model for end-stage liver disease score; CP score: Child-Pugh score; HBV-DC: HBV-related-decompensated cirrhosis.